CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label Dose Escalation Study of Intravenous Paricalcitol (ZEMPLAR™) [19-NOR-1 ALPHA, 25 - (OH)D] With Zoledronic Acid (Zometa™) in Patients With Multiple Myeloma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00258258
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:22.731182+00:00
Published At: 2013-02-01T00:00:00+00:00
Record Updated At: 2013-02-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Multiple Myeloma and Plasma Cell Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-02-01"
protocolSection.identificationModule.nctId: "NCT00258258"
protocolSection.identificationModule.officialTitle: "An Open Label Dose Escalation Study of Intravenous Paricalcitol (ZEMPLAR\u2122) [19-NOR-1 ALPHA, 25 - (OH)D] With Zoledronic Acid (Zometa\u2122) in Patients With Multiple Myeloma"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.